103 related articles for article (PubMed ID: 32942305)
61. Relationship between cellular radiosensitivity and non-repaired double-strand breaks studied for different growth states, dose rates and plating conditions in a normal human fibroblast line.
Dikomey E; Brammer I
Int J Radiat Biol; 2000 Jun; 76(6):773-81. PubMed ID: 10902731
[TBL] [Abstract][Full Text] [Related]
62. Influence of Gadolinium-Based Contrast Agents on Tissue Sodium Quantification in Sodium Magnetic Resonance Imaging.
Paschke NK; Neumann W; Uhrig T; Winkler M; Neumaier-Probst E; Fatar M; Schad LR; Zöllner FG
Invest Radiol; 2018 Sep; 53(9):555-562. PubMed ID: 29863602
[TBL] [Abstract][Full Text] [Related]
63. Increased radiotoxicity in two cancerous cell lines irradiated by low and high energy photons in the presence of thio-glucose bound gold nanoparticles.
Soleymanifard S; Rostami A; Aledavood SA; Matin MM; Sazgarnia A
Int J Radiat Biol; 2017 Apr; 93(4):407-415. PubMed ID: 27921518
[TBL] [Abstract][Full Text] [Related]
64. BrdUrd-induced radiosensitization of two human tumour cell lines at iso-levels of incorporation.
Franken NA; Van Bree C; Kipp JB; Rodermond HM; Haveman J; Barendsen GW
Oncol Rep; 2000; 7(5):937-40. PubMed ID: 10948317
[TBL] [Abstract][Full Text] [Related]
65. Targeting DNA-dependent protein kinase sensitizes hepatocellular carcinoma cells to proton beam irradiation through apoptosis induction.
Choi C; Son A; Lee GH; Shin SW; Park S; Ahn SH; Chung Y; Yu JI; Park HC
PLoS One; 2019; 14(6):e0218049. PubMed ID: 31194786
[TBL] [Abstract][Full Text] [Related]
66. β-elemene enhances the radiosensitivity of gastric cancer cells by inhibiting Pak1 activation.
Liu JS; Che XM; Chang S; Qiu GL; He SC; Fan L; Zhao W; Zhang ZL; Wang SF
World J Gastroenterol; 2015 Sep; 21(34):9945-56. PubMed ID: 26379399
[TBL] [Abstract][Full Text] [Related]
67. Radiopotentiation by the oral platinum agent, JM216: role of repair inhibition.
Amorino GP; Freeman ML; Carbone DP; Lebwohl DE; Choy H
Int J Radiat Oncol Biol Phys; 1999 May; 44(2):399-405. PubMed ID: 10760436
[TBL] [Abstract][Full Text] [Related]
68. Attenuation of the DNA damage response by transforming growth factor-beta inhibitors enhances radiation sensitivity of non-small-cell lung cancer cells in vitro and in vivo.
Du S; Bouquet S; Lo CH; Pellicciotta I; Bolourchi S; Parry R; Barcellos-Hoff MH
Int J Radiat Oncol Biol Phys; 2015 Jan; 91(1):91-9. PubMed ID: 25835621
[TBL] [Abstract][Full Text] [Related]
69. Long-term Excretion of Gadolinium-based Contrast Agents: Linear versus Macrocyclic Agents in an Experimental Rat Model.
Jost G; Frenzel T; Boyken J; Lohrke J; Nischwitz V; Pietsch H
Radiology; 2019 Feb; 290(2):340-348. PubMed ID: 30422091
[TBL] [Abstract][Full Text] [Related]
70. Expression levels of the DNA repair enzyme HAP1 do not correlate with the radiosensitivities of human or HAP1-transfected rat cell lines.
Herring CJ; Deans B; Elder RH; Rafferty JA; MacKinnon J; Barzilay G; Hickson ID; Hendry JH; Margison GP
Br J Cancer; 1999 Jun; 80(7):940-5. PubMed ID: 10362100
[TBL] [Abstract][Full Text] [Related]
71. Gadopentetate dimeglumine as an intradiscal contrast agent.
Huang TS; Zucherman JF; Hsu KY; Shapiro M; Lentz D; Gartland J
Spine (Phila Pa 1976); 2002 Apr; 27(8):839-43. PubMed ID: 11935106
[TBL] [Abstract][Full Text] [Related]
72. Exposure of Macrophages to Low-Dose Gadolinium-Based Contrast Medium: Impact on Oxidative Stress and Cytokines Production.
Weng TI; Chen HJ; Lu CW; Ho YC; Wu JL; Liu SH; Hsiao JK
Contrast Media Mol Imaging; 2018; 2018():3535769. PubMed ID: 30627059
[TBL] [Abstract][Full Text] [Related]
73. Comparison of gadolinium nanoparticles and molecular contrast agents for radiation therapy-enhancement.
Delorme R; Taupin F; Flaender M; Ravanat JL; Champion C; Agelou M; Elleaume H
Med Phys; 2017 Nov; 44(11):5949-5960. PubMed ID: 28886212
[TBL] [Abstract][Full Text] [Related]
74. Assessment of alterations in X-ray irradiation-induced DNA damage of glioma cells by using proton nuclear magnetic resonance spectroscopy.
Li H; Xu Y; Shi W; Li F; Zeng Q; Yi C
Int J Biochem Cell Biol; 2017 Mar; 84():109-118. PubMed ID: 28122253
[TBL] [Abstract][Full Text] [Related]
75. Modifications of the radiosensitivity of a renal cancer cell line as a consequence of stable TIMP-1 overexpression.
Smyth A; Reid HM; Baker AH; McGlynn H
Int J Radiat Biol; 2007 Jan; 83(1):13-25. PubMed ID: 17357436
[TBL] [Abstract][Full Text] [Related]
76. Targeting apoptosis by hydroxymethylacylfulvene in combination with gamma radiation in prostate tumor cells.
Woynarowska BA; Roberts K; Woynarowski JM; MacDonald JR; Herman TS
Radiat Res; 2000 Oct; 154(4):429-38. PubMed ID: 11023607
[TBL] [Abstract][Full Text] [Related]
77. Multifunctional terpolymeric MRI contrast agent with superior signal enhancement in blood and tumor.
Shalviri A; Foltz WD; Cai P; Rauth AM; Wu XY
J Control Release; 2013 Apr; 167(1):11-20. PubMed ID: 23353806
[TBL] [Abstract][Full Text] [Related]
78. Relationship between p53 status and radiosensitivity in human tumour cell lines.
Siles E; Villalobos M; Valenzuela MT; Núñez MI; Gordon A; McMillan TJ; Pedraza V; Ruiz de Almodóvar JM
Br J Cancer; 1996 Mar; 73(5):581-8. PubMed ID: 8605090
[TBL] [Abstract][Full Text] [Related]
79. Radiation responses of Sf9, a highly radioresistant lepidopteran insect cell line.
Chandna S; Dwarakanath BS; Seth RK; Khaitan D; Adhikari JS; Jain V
Int J Radiat Biol; 2004 Apr; 80(4):301-15. PubMed ID: 15204707
[TBL] [Abstract][Full Text] [Related]
80. Impact of gadolinium-based contrast agents on the growth of fish cells lines.
Parant M; Sohm B; Flayac J; Perrat E; Chuburu F; Cadiou C; Rosin C; Cossu-Leguille C
Ecotoxicol Environ Saf; 2019 Oct; 182():109385. PubMed ID: 31260918
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
